English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
How azacitidine works
Share :
ASH 50th annual meeting 2008
6 - 9 Dec 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
19 Feb 2009
Views:
21203
Rating:
Save
Rate video
Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
How azacitidine / vidaza works, epigenetics and vidaza, the difference vidaza makes for patients. Interviewed at ASH 2008.
Categories:
Haematology oncology
Biology
Drug development
Related Videos
Multiple myeloma in a resource constrained setting
Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda
22 Feb 2024
Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and...
Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal
25 Jan 2024
Ide-cell enhances health-related quality of life for refractory multiple myeloma
Dr Michel Delforge - University Hospital Leuven, Leuven, Belgium
24 Dec 2023
Adding nivolumab to R-GemOx shows enhanced efficacy in treating R/R large B...
Dr Gerhard Held - Westpfalz-Klinikum, Kaiserslautern, Germany
20 Dec 2023
Ponatinib is superior to imatinib in combination with chemotherapy for newly...
Dr Elias Jabbour - MD Anderson Cancer Center, Houston, USA
19 Dec 2023
Relapsed Refractory Multiple Myeloma
Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
5 Dec 2023
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Dr Gabriele Casirati - Dana-Farber Cancer Institute, Boston, USA
3 Oct 2023
Real-world use of brexu-cel shows benefit in R/R mantle cell lymphoma treatment
Dr Nausheen Ahmed - The University of Kansas Cancer, Kansas, USA
23 Jun 2023
Venetoclax and ibrutinib therapy shows favourable results in the treatment of R...
Prof Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands
22 Jun 2023
More from
e
cancer